Navigating the complex world of chemical compounds requires reliable information and consistent access to high-quality materials. CAS 1004-76-8, chemically known as 2-Mercapto-4-hydroxy-5,6-diaminopyrimidine, is one such compound that demands attention due to its significant utility in key industries. NINGBO INNO PHARMCHEM CO.,LTD. aims to be your go-to resource for understanding and sourcing this versatile chemical.

This compound, with its molecular formula C4H6N4OS and molecular weight of 158.18, is characterized as a pale yellow solid. Its primary recognition comes from its role as a critical intermediate in the pharmaceutical industry, particularly for the synthesis of anticancer and analgesic agents. The ability to buy this specific intermediate from a reputable manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. is vital for ensuring the success of complex drug synthesis projects. The consistent purity and reliable supply are foundational for pharmaceutical research and development teams striving to bring new therapies to market.


Beyond its pharmaceutical applications, 2-Mercapto-4-hydroxy-5,6-diaminopyrimidine also serves a crucial function in the electronics sector as a component in photoresist chemicals. This highlights its versatility, making it a compound of interest for a wide range of applications. For businesses involved in semiconductor manufacturing or other electronic processes that rely on advanced photoresist formulations, securing a dependable source for CAS 1004-76-8 is essential.


Furthermore, the compound exhibits antioxidative activity, suggesting potential applications in treatments for oxidative stress-related diseases. This emergent property adds to its overall value, making it an attractive option for researchers exploring novel therapeutic avenues. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting these diverse scientific and industrial endeavors by providing high-quality chemical products. As a trusted supplier, we ensure that our clients receive the materials they need to drive innovation forward, whether for cutting-edge pharmaceutical research or advancements in electronic technologies.